Search Results 1461-1470 of 12861 for Transient

  1. Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA) - Mayo Clinic

    Participation eligibility · A history of myocardial infarction, stroke, transient ischemic attack or revascularization procedure to prevent any of these events; ...

  2. A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients with CAA - Mayo Clinic

    Presentation with spontaneous intracerebral hemorrhage, transient focal neurological episodes or cognitive impairment or dementia. At least 2 strictly lobar ...

  3. Artificial Intelligence Models in Electrocardiogram Interpretation for Identification of Advanced Liver Disease - Mayo Clinic

    Patients with Chronic Liver Disease undergoing Transient Elastography (Fibroscan). Exclusion Criteria: Individuals under the age of 18. Eligibility last ...

  4. Atrial Fibrillation Clinical Trials - Mayo Clinic Research

    The purpose of this study is to verify that high Premature Ventricular Complex (PVC) burden is associated with increased risk of stroke and/or Transient ...

  5. https://www.mayoclinic.org/chinese_organization_concepts.xml

  6. NRG-GY012 “A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, And The Combinations Of Cediranib/Olaparib, Olaparib/Durvalumab (MEDI4736), Cediranib/Durvalumab (MEDI4736), Olaparib/AZD5356 (Capivasertib) In Women With Recurrent, Persistent Or Metastatic Endometrial Cancer. A Multi-Arm Trial For Women With Recurrent Or Persistent Endometrial Cancer” - Mayo Clinic

    Prior history of stroke or transient ischemic attack within the last 6 months. Prior history of hypertensive crisis or hypertensive encephalopathy. Major ...

  7. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

  8. https://www.mayoclinic.org/spanish_organization_concepts.xml

  9. A Study to Evaluate Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC - Mayo Clinic

    Subjects with history of myocardial infarction, transient ischemic attack, or stroke in the past 6 months. Congestive heart failure ≥ Class 3 based on New ...

  10. A study to test whether survodutide helps people with a liver disease called NASH/MASH who have cirrhosis - Mayo Clinic

    ... transient ischaemic attack, and/or acute peripheral vascular event. HF with New York Heart Association (NYHA) functional class IV or known left ventricular ...